CoChat

Corticotropin Releasing Factor promotes breast cancer cell motility and invasiveness

Open access

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

Abstract

Introduction: Cancer cells secrete bioactive peptides that act in an autocrine or paracrine fashion affecting tumor growth and metastasis. Corticotropin-releasing factor (CRF), a hypothalamic neuropeptide that controls the response to stress, has been detected in breast cancer tissues and cell lines. CRF can affect breast cancer cells in an autocrine or paracrine manner via its production from innervating sympathetic neurons or immune cells. Methods: In the present study we report our findings regarding the impact of CRF on breast cancer cell motility and invasiveness. For this purpose we used the MCF7 breast cancer cell line and evaluated the effect of CRF on motility and invasiveness using the wound-healing and boyden-chamber assays. In addition, we measured the effect of CRF on molecules that mediate motility by western blot, immunofluorescence, ELISA and RT-PCR. Results: Our findings show that: 1. CRF transiently inhibited the apoptosis of MCF7 cells. 2. CRF enhanced MCF7 cell motility in a wound healing assay and their invasiveness through extracellular matrix. 3. CRF increased actin polymerization, phosphorylation of Focal Adhesion Kinase (FAK), providing a potential mechanism for the observed induction of MCF7 motility. 4. CRF induced the expression of Cox-1 but not Cox-2 in MCF7 cells as well as the production of prostaglandins, factors known to promote invasiveness and metastasis. Conclusion: Overall, our data suggest that CRF stimulates cell motility and invasiveness of MCF7 cells most probably via induction of FAK phosphorylation and actin filament reorganization and production of prostaglandins via Cox1. Based on these findings we postulate that the stress neuropeptide CRF present in the vicinity of tumors (either produced locally by the tumor cells themselves or by nearby normal cells or secreted from the innervations of surrounding tissues) may play an important role on breast tumor growth and metastatic capacity, providing a potential link between stress and tumor progression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1476-4598-8-30

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 CRF1a and CRF2c are expressed in MCF7 cells as detected by RT-PCR. Total RNA was isolated from MCF7 cells and the expression of CRF receptors subtypes CRF1a, CRF1b, CRF2a and CRF2c were detected by semi-quantitative RT-PCR. The levels of beta Actin were also measured as a normalization control. Results are representative of three independent experiments.
Figure 1 CRF1a and CRF2c are expressed in MCF7 cells as detected by RT-PCR. Total RNA was isolated from MCF7 cells and the expression of CRF receptors subtypes CRF1a, CRF1b, CRF2a and CRF2c were detected by semi-quantitative RT-PCR. The levels of beta Actin were also measured as a normalization control. Results are representative of three independent experiments.CC BY · PubMed Central
Figure 2 CRF affected proliferation and apoptosis of MCF7 cells in a time dependent manner. Cells were stimulated with 10-8 M CRF or vehicle (control) for 24, 48, and 72 hours, and cell growth was measured using the MTT assay (A); apoptosis was measured by the ApoPercentage Assay (B). CRF significantly suppressed proliferation at all time points tested and apoptosis 48 hours after CRF stimulation. Data are expressed as % of control (unstimulated cells). Results represent the average of 4 independent experiments where each condition was assayed in triplicate. *p < 0.05; **p < 0.01 compared to control cells at the same time point.
Figure 2 CRF affected proliferation and apoptosis of MCF7 cells in a time dependent manner. Cells were stimulated with 10-8 M CRF or vehicle (control) for 24, 48, and 72 hours, and cell growth was measured using the MTT assay (A); apoptosis was measured by the ApoPercentage Assay (B). CRF significantly suppressed proliferation at all time points tested and apoptosis 48 hours after CRF stimulation. Data are expressed as % of control (unstimulated cells). Results represent the average of 4 independent experiments where each condition was assayed in triplicate. *p < 0.05; **p < 0.01 compared to control cells at the same time point.CC BY · PubMed Central
Figure 3 CRF induces the motility of MCF7 in a wound healing assay. MCF7 cells were stimulated with 10-8 M CRF or vehicle (control) and photographed at 0, 6, 12 and 24 hours after disruption of a small area of the cell layer. The remigration of the cells was quantified by measuring the distance at 3 at least different positions on each image with the program Image J, and expressed the distance as % of the average. Results represent the average of three independent experiments. *p < 0.05; **p < 0.01 compared to control cells at the same time point.
Figure 3 CRF induces the motility of MCF7 in a wound healing assay. MCF7 cells were stimulated with 10-8 M CRF or vehicle (control) and photographed at 0, 6, 12 and 24 hours after disruption of a small area of the cell layer. The remigration of the cells was quantified by measuring the distance at 3 at least different positions on each image with the program Image J, and expressed the distance as % of the average. Results represent the average of three independent experiments. *p < 0.05; **p < 0.01 compared to control cells at the same time point.CC BY · PubMed Central
Figure 4 CRF enhances the invasion of MCF7 through ECM via CRF1. MCF7 cells were stimulated with 10-8 M CRF or vehicle (control) and the invasion assay was performed according to the manufacturer's instructions. CRF augmented the invasion of the cells through the ECM. Pretreatment with the CRF1 antagonist (10-6 M) abrogated the effect of CRF. Results represent the average of two independent experiments where each condition was assayed in triplicate. **p < 0.01 compared to untreated controls; #p < 0.05 compared to CRF-treated samples.
Figure 4 CRF enhances the invasion of MCF7 through ECM via CRF1. MCF7 cells were stimulated with 10-8 M CRF or vehicle (control) and the invasion assay was performed according to the manufacturer's instructions. CRF augmented the invasion of the cells through the ECM. Pretreatment with the CRF1 antagonist (10-6 M) abrogated the effect of CRF. Results represent the average of two independent experiments where each condition was assayed in triplicate. **p < 0.01 compared to untreated controls; #p < 0.05 compared to CRF-treated samples.CC BY · PubMed Central
Figure 5 A. CRF affects actin cytoskeleton. MCF7 cells were plated in chamber-slides, stimulated with 10-8 M CRF or vehicle (control) for 1, 3 and 6 hours and stained with rhodamine-phalloidine. Fluorescence was measured by confocal microscopy. Results are representative of three independent experiments.B. CRF induces actin polymerization. MCF7 cells were stimulated with CRF (10-8 M) or vehicle (control) for 3 and 6 hours. Cells were harvested and the two fractions, soluble and insoluble, containing the monomeric (globular) and the polymerized (filamentous) actin respectively were isolated and analyzed by western blotting using antibody against actin. The relative proportion of F- and G-actin was determined by the concentration of monomeric (G) and total (F+G) actin and the result is presented as the G/(F+G) ratio induced by CRF compared to control; p < 0,01. Results represent the average of five independent experiments.
Figure 5 A. CRF affects actin cytoskeleton. MCF7 cells were plated in chamber-slides, stimulated with 10-8 M CRF or vehicle (control) for 1, 3 and 6 hours and stained with rhodamine-phalloidine. Fluorescence was measured by confocal microscopy. Results are representative of three independent experiments.B. CRF induces actin polymerization. MCF7 cells were stimulated with CRF (10-8 M) or vehicle (control) for 3 and 6 hours. Cells were harvested and the two fractions, soluble and insoluble, containing the monomeric (globular) and the polymerized (filamentous) actin respectively were isolated and analyzed by western blotting using antibody against actin. The relative proportion of F- and G-actin was determined by the concentration of monomeric (G) and total (F+G) actin and the result is presented as the G/(F+G) ratio induced by CRF compared to control; p < 0,01. Results represent the average of five independent experiments.CC BY · PubMed Central
Figure 6 CRF induces the phosphorylation of FAK. MCF7 cells were treated with CRF (10-8 M) or vehicle (control) for 3 hours, stained with phospho-FAK antibody and analyzed with confocal microscopy. Result is representative of three independent experiments.
Figure 6 CRF induces the phosphorylation of FAK. MCF7 cells were treated with CRF (10-8 M) or vehicle (control) for 3 hours, stained with phospho-FAK antibody and analyzed with confocal microscopy. Result is representative of three independent experiments.CC BY · PubMed Central
Figure 7 CRF induces the expression of Cox-1 and the production of prostaglandins. A. MCF7 cells were treated with CRF (10-8 M) or vehicle (control) for 6 and16 hours and total prostaglandin production in the supernatant was measured by ELISA; ***p < 0.001; Results represent the average of three independent experiments. B. MCF7 cells were treated with CRF (10-8 M) for 3, 6 and 24 hours and Cox-2 was measured by western blot. C. MCF7 cells were treated with CRF (10-8 M) for 6, 12 and 24 hours and Cox-1 was measured by western blot. Results are representative of three independent experiments.
Figure 7 CRF induces the expression of Cox-1 and the production of prostaglandins. A. MCF7 cells were treated with CRF (10-8 M) or vehicle (control) for 6 and16 hours and total prostaglandin production in the supernatant was measured by ELISA; ***p < 0.001; Results represent the average of three independent experiments. B. MCF7 cells were treated with CRF (10-8 M) for 3, 6 and 24 hours and Cox-2 was measured by western blot. C. MCF7 cells were treated with CRF (10-8 M) for 6, 12 and 24 hours and Cox-1 was measured by western blot. Results are representative of three independent experiments.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Show all 62 references

Cited by

See all 66

Metadata

Authors
Androulidaki, A., Dermitzaki, E., Venihaki, M., Karagianni, E., Rassouli, O., Andreakou, E., Stournaras, C., Margioris, A. N., & Tsatsanis, C.
Affiliations
University of Crete (GR)
Corresponding author
  • Margioris, Andrew N
  • Tsatsanis, Christos
Venue
Molecular Cancer
Published
2009-06-02
Volume
8
Issue
1
Pages
30-30
ISSN
1476-4598 (ISSN-L)
OpenAlex
W2138640721
Cited by
58
References
59
Citations by year
2026: 8 · 2025: 5 · 2024: 2 · 2023: 4 · 2022: 5 · 2021: 1 · 2020: 3 · 2019: 1 · 2018: 2 · 2017: 3 · 2015: 4 · 2014: 4 · 2013: 5 · 2012: 1
FWCI
2.26
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Molecular Cancer (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
Keywords
corticotropin-releasing factor, breast cancer, cell motility, tumor invasion, MCF-7 cells, apoptosis inhibition, focal adhesion kinase phosphorylation, actin polymerization, cyclooxygenase-1, prostaglandins, metastasis, tumor microenvironment
MeSH terms
Actins, Analysis of Variance, Breast Neoplasms, Cell Movement, Corticotropin-Releasing Hormone, Enzyme-Linked Immunosorbent Assay, Female, Fluorescent Antibody Technique, Humans, Neoplasm Invasiveness, Phosphorylation, Prostaglandins, Blotting, Western, Apoptosis, Reverse Transcriptase Polymerase Chain Reaction, Cell Line, Tumor, Focal Adhesion Kinase 1, Cyclooxygenase 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Corticotropin Releasing Factor promotes breast cancer cell motility and invasiveness. https://app.cochat.ai/papers/10.1186/1476-4598-8-30
The paper
Androulidaki, A., Dermitzaki, E., Venihaki, M., Karagianni, E., Rassouli, O., Andreakou, E., Stournaras, C., Margioris, A. N., & Tsatsanis, C. (2009). Corticotropin Releasing Factor promotes breast cancer cell motility and invasiveness. Molecular Cancer. https://doi.org/10.1186/1476-4598-8-30

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.